Other Viruses Citation List: April 25 - May 8, 2014
Hepatitis B Virus
1. Monoclonal Antibodies to Various Epitopes of Hepatitis B Surface Antigen Inhibit Hepatitis B Virus Infection. Golsaz Shirazi, F., H. Mohammadi, M.M. Amiri, K. Singethan, Y. Xia, A.A. Bayat, M. Bahadori, H. Rabbani, M. Jeddi-Tehrani, U. Protzer, and F. Shokri. Journal of Gastroenterology and Hepatology, 2014. 29(5): p. 1083-1091; PMID[24325676].
[PubMed]. OV_0425-050814.
2. Stereoselective Synthesis of 2'-Fluoro-6'-methylene carbocyclic adenosine via Vince Lactam. Singh, U.S., R.C. Mishra, R. Shankar, and C.K. Chu. The Journal of Organic Chemistry, 2014. 79(9): p. 3917-3923; PMID[24697270].
[PubMed]. OV_0425-050814.
Hepatitis C Virus
3. Key Binding and Susceptibility of NS3/4A Serine Protease Inhibitors against Hepatitis C Virus. Meeprasert, A., S. Hannongbua, and T. Rungrotmongkol. Journal of Chemical Information and Modeling, 2014. 54(4): p. 1208-1217; PMID[24689657].
[PubMed]. OV_0425-050814.
4. Discovery of 2-Iminobenzimidazoles as Potent Hepatitis C Virus Inhibitors with a Novel Mechanism of Action. Windisch, M.P., S. Jo, H.Y. Kim, S.H. Kim, K. Kim, S. Kong, H. Jeong, S. Ahn, Z. No, and J.Y. Hwang. European Journal of Medicinal Chemistry, 2014. 78: p. 35-42; PMID[24675178].
[PubMed]. OV_0425-050814.
5. New Pyrazolobenzothiazine Derivatives as Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors. Manfroni, G., D. Manvar, M.L. Barreca, N. Kaushik-Basu, P. Leyssen, J. Paeshuyse, R. Cannalire, N. Iraci, A. Basu, M. Chudaev, C. Zamperini, E. Dreassi, S. Sabatini, O. Tabarrini, J. Neyts, and V. Cecchetti. Journal of Medicinal Chemistry, 2014. 57(8): p. 3247-3262; PMID[24654886].
[PubMed]. OV_0425-050814.
6. Synthesis and anti-HCV Entry Activity Studies of beta-Cyclodextrin-pentacyclic triterpene Conjugates. Xiao, S., Q. Wang, L. Si, Y. Shi, H. Wang, F. Yu, Y. Zhang, Y. Li, Y. Zheng, C. Zhang, C. Wang, L. Zhang, and D. Zhou. ChemMedChem, 2014. 9(5): p. 1060-1070; PMID[24623716].
[PubMed]. OV_0425-050814.
7. Intracellular Effects of the Hepatitis C Virus Nucleoside Polymerase Inhibitor RO5855 (Mericitabine Parent) and Ribavirin in Combination. Ma, H., S. Le Pogam, S. Fletcher, F. Hinojosa-Kirschenbaum, H. Javanbakht, J.M. Yan, W.R. Jiang, N. Inocencio, K. Klumpp, and I. Najera. Antimicrobial Agents and Chemotherapy, 2014. 58(5): p. 2614-2625; PMID[24550342].
[PubMed]. OV_0425-050814.
Epstein-Barr Virus
8. Identification and Characterization of Small Molecule Modulators of the Epstein-Barr Virus-induced Gene 2 (EBI2) Receptor. Gessier, F., I. Preuss, H. Yin, M.M. Rosenkilde, S. Laurent, R. Endres, Y.A. Chen, T.H. Marsilje, K. Seuwen, D.G. Nguyen, and A.W. Sailer. Journal of Medicinal Chemistry, 2014. 57(8): p. 3358-3368; PMID[24678947].
[PubMed]. OV_0425-050814.
Herpes Simplex Virus 1
9. A Dihydro-pyrido-indole Potently Inhibits HSV-1 Infection by Interfering the Viral Immediate Early Transcriptional Events. Bag, P., D. Ojha, H. Mukherjee, U.C. Halder, S. Mondal, A. Biswas, A. Sharon, L. Van Kaer, S. Chakrabarty, G. Das, D. Mitra, and D. Chattopadhyay. Antiviral Research, 2014. 105: p. 126-134; PMID[24576908].
[PubMed]. OV_0425-050814.
10. Silencing Herpes Simplex Virus Type 1 Capsid Protein Encoding Genes by siRNA: A Promising Antiviral Therapeutic Approach. Jin, F., S. Li, K. Zheng, C. Zhuo, K. Ma, M. Chen, Q. Wang, P. Zhang, J. Fan, Z. Ren, and Y. Wang. Plos One, 2014. 9(5): p. e96623; PMID[24794394].
[PubMed]. OV_0425-050814.
11. Nelfinavir Inhibits Maturation and Export of Herpes Simplex Virus 1. Kalu, N.N., P.J. Desai, C.M. Shirley, W. Gibson, P.A. Dennis, and R.F. Ambinder. Journal of Virology, 2014. 88(10): p. 5455-5461; PMID[24574416].
[PubMed]. OV_0425-050814.
12. Tranylcypromine Reduces Herpes Simplex Virus 1 Infection in Mice. Yao, H.W., P.H. Lin, F.H. Shen, G.C. Perng, Y.Y. Tung, S.M. Hsu, and S.H. Chen. Antimicrobial Agents and Chemotherapy, 2014. 58(5): p. 2807-2815; PMID[24590478].
[PubMed]. OV_0425-050814.
13. Chemical Characterization and Antiherpes Activity of Sulfated Polysaccharides from Lithothamnion muelleri. Malagoli, B.G., F.T. Cardozo, J.H. Gomes, V.P. Ferraz, C.M. Simoes, and F.C. Braga. International Journal of Biological Macromolecules, 2014. 66: p. 332-337; PMID[24608026].
[PubMed]. OV_0425-050814.
Citations from the ISI Web of Knowledge Listings for O.V.
14. Stearoyl-CoA Desaturase Inhibition Blocks Formation of Hepatitis C Virus-induced Specialized Membranes. Lyn, R.K., R. Singaravelu, S. Kargman, S. O'Hara, H. Chan, R. Oballa, Z. Huang, D.M. Jones, A. Ridsdale, R.S. Russell, A.W. Partridge, and J.P. Pezacki. Scientific Reports, 2014. 4: 4549; ISI[000333555300014].
[WOS]. OV_0425-050814.
15. Synthesis, Antiviral Evaluation, and Computational Studies of Cyclobutane and Cyclobutene L- Nucleoside Analogues. Miralles-Lluma, R., A. Figueras, F. Busque, A. Alvarez-Larena, J. Balzarini, M. Figueredo, J. Font, R. Alibes, and J.D. Marechal. European Journal of Organic Chemistry, 2013. 2013(34): p. 7761-7775; ISI[000332831100007].
[WOS]. OV_0425-050814.
16. Hepatitis B and C: From Molecular Virology to New Antiviral Therapies (Part 2). Thimme, R., M. Heim, T.F. Baumert, M. Nassal, and D. Moradpour. Deutsche Medizinische Wochenschrift, 2014. 139(15): p. 778-782; ISI[000333681600011].
[WOS]. OV_0425-050814.